Defence Therapeutics Inc. (CSE:DTC)
Canada · Delayed Price · Currency is CAD 0.4900
-0.0100 (-2.00%)
Sep 17, 2026, 5:26 PM EST
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of CAD 37.14 million as of September 18, 2026. Its market cap has decreased by -3.06% in one year.
Market Cap
37.14M
Enterprise Value
35.75M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.49
ChartMarket Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 89.08M to 37.14M, a decrease of -58.31%. That is a compound annual growth rate of -15.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 37.14M | -10.10% |
| Dec 31, 2025 | 41.31M | 31.21% |
| Dec 31, 2024 | 31.48M | -69.62% |
| Dec 29, 2023 | 103.61M | 5.29% |
| Dec 30, 2022 | 98.41M | -49.44% |
| Dec 31, 2021 | 194.63M | 118.48% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MedMira | 45.61M |
| BriaCell Therapeutics | 43.32M |
| Sharp Therapeutics | 43.26M |
| Sona Nanotech | 42.98M |
| Microbix Biosystems | 42.46M |
| Sernova Biotherapeutics | 39.65M |
| Medicenna Therapeutics | 36.92M |
| Telescope Innovations | 36.17M |